4P-Pharma

Focus: 4P-Pharma is a small French pharmaceutical company (1-50 employees) based in Lille, founded in 2014, operating across small molecules, biologics, and generics.

Infectious Diseases

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Employees

1-50

Open Jobs

About 4P-Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow 4P-Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

1 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Plerixafor 20 MG/ML [Mozobil]

COVID-19 Acute Respiratory Distress Syndrome

Phase 2

Clinical Trials (1)

NCT05411575Plerixafor in Acute Respiratory Distress Syndrome Related to COVID-19 (Phase IIb)

Phase 2

Help build intelligence for 4P-Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage environment offers hands-on exposure across multiple modalities (small molecules, biologics, generics) with broad learning potential
Founded 2014 and publicly listed suggests successful transition through growth milestones and investor confidence
Small team size (<50 employees) enables direct impact and close collaboration across functions

Watch Out For

No active clinical pipeline, product portfolio, or revenue reported—indicates early pre-commercial or acquisition/restructuring phase with execution risk
Zero active job openings suggest limited near-term hiring or potential financial/operational constraints
Minimal public data on financials, pipeline depth, or strategic direction limits transparency for career planning

Generated by Claude from 4P-Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Founded: 2014

Portfolio: 1 clinical trial

Top TAs: Infectious Diseases

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

Infectious Diseases

1 pipeline

Marketed

Pipeline